Soy and red clover for mid-life and aging - PubMed (original) (raw)
Review
Soy and red clover for mid-life and aging
S E Geller et al. Climacteric. 2006 Aug.
Abstract
Introduction: Menopause is associated with mid-life, a time when many women begin to experience the signs and symptoms of aging, such as increases in blood pressure, changes in lipid profiles, loss of bone mass density, and diminished memory and cognition. Given the result of the Women's Health Initiative, many women no longer consider hormone therapy the first option for promoting healthy aging. Instead, they are turning to botanical and dietary supplement (BDS) products in place of hormone therapy. This paper reviews the evidence available for use of isoflavones from soy and red clover for the treatment or prevention of these health issues.
Methods: The MEDLINE and EMBASE databases were searched for articles relating to soy or red clover supplement use for prevention and/or treatment of heart disease, hyperlipidemia, osteoporosis, mood disorders and cognitive abilities. Studies were included if they were randomized, controlled trials and included peri- or postmenopausal women.
Results: Isoflavone products appear to be the most useful for improving lipid profiles; however, the evidence suggests that isoflavone extracts from soy are less effective than products containing soy protein or red clover isoflavones. Soy protein appears to reduce levels of total cholesterol and low density lipoprotein cholesterol, while red clover reduces levels of triglycerides and increases high density lipoprotein cholesterol. The data were somewhat less convincing, although promising, for increasing bone mass density and improving cognitive abilities.
Conclusions: Research suggests that isoflavones found in soy foods and red clover appear to have a small but positive health effect on plasma lipid concentrations, bone mass density, and cognitive abilities. Given the lack of serious safety concerns in the short term, it would appear that including soy and red clover in the diet of postmenopausal women, not withstanding a soy allergy, might be beneficial.
Conflict of interest statement
Conflict of Interest Statement:
The authors have no conflicts of interest to report.
Similar articles
- The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study.
Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel G. Hidalgo LA, et al. Gynecol Endocrinol. 2005 Nov;21(5):257-64. doi: 10.1080/09513590500361192. Gynecol Endocrinol. 2005. PMID: 16373244 Clinical Trial. - Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.
Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW, van der Schouw YT. Kreijkamp-Kaspers S, et al. JAMA. 2004 Jul 7;292(1):65-74. doi: 10.1001/jama.292.1.65. JAMA. 2004. PMID: 15238592 Clinical Trial. - Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review.
Booth NL, Piersen CE, Banuvar S, Geller SE, Shulman LP, Farnsworth NR. Booth NL, et al. Menopause. 2006 Mar-Apr;13(2):251-64. doi: 10.1097/01.gme.0000198297.40269.f7. Menopause. 2006. PMID: 16645539 Review. - The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women.
Fournier LR, Ryan Borchers TA, Robison LM, Wiediger M, Park JS, Chew BP, McGuire MK, Sclar DA, Skaer TL, Beerman KA. Fournier LR, et al. J Nutr Health Aging. 2007 Mar-Apr;11(2):155-64. J Nutr Health Aging. 2007. PMID: 17435957 Clinical Trial. - Botanical and dietary supplements for menopausal symptoms: what works, what does not.
Geller SE, Studee L. Geller SE, et al. J Womens Health (Larchmt). 2005 Sep;14(7):634-49. doi: 10.1089/jwh.2005.14.634. J Womens Health (Larchmt). 2005. PMID: 16181020 Free PMC article. Review.
Cited by
- Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Inpan R, Na Takuathung M, Sakuludomkan W, Dukaew N, Teekachunhatean S, Koonrungsesomboon N. Inpan R, et al. Osteoporos Int. 2024 Mar;35(3):413-430. doi: 10.1007/s00198-023-06944-y. Epub 2023 Oct 25. Osteoporos Int. 2024. PMID: 37875614 Review. - A review on therapeutic mechanism of medicinal plants against osteoporosis: effects of phytoconstituents.
Kumari S, Singh M, Nupur, Jain S, Verma N, Malik S, Rustagi S, Priya K. Kumari S, et al. Mol Biol Rep. 2023 Nov;50(11):9453-9468. doi: 10.1007/s11033-023-08751-4. Epub 2023 Sep 7. Mol Biol Rep. 2023. PMID: 37676432 Review. - A Graded Approach for Evaluating Health Claims about Plant-Based Food Supplements: Application of a Case Study Methodology.
Chevallier H, Herpin F, Kergosien H, Ventura G, Allaert FA. Chevallier H, et al. Nutrients. 2021 Aug 2;13(8):2684. doi: 10.3390/nu13082684. Nutrients. 2021. PMID: 34444844 Free PMC article. - Botanicals in Postmenopausal Osteoporosis.
Słupski W, Jawień P, Nowak B. Słupski W, et al. Nutrients. 2021 May 11;13(5):1609. doi: 10.3390/nu13051609. Nutrients. 2021. PMID: 34064936 Free PMC article. Review. - Dual Function of a Novel Bacterium, Slackia sp. D-G6: Detoxifying Deoxynivalenol and Producing the Natural Estrogen Analogue, Equol.
Gao X, Mu P, Zhu X, Chen X, Tang S, Wu Y, Miao X, Wang X, Wen J, Deng Y. Gao X, et al. Toxins (Basel). 2020 Jan 26;12(2):85. doi: 10.3390/toxins12020085. Toxins (Basel). 2020. PMID: 31991913 Free PMC article.
References
- Whiteman MK, Staropoli CA, Benedict JC, Borgeest C, Flaws JA. Risk factors for hot flashes in midlife women. J Womens Health. 2003;12:459–472. - PubMed
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–333. - PubMed
- Botanicals and Botanical Preparations widely used as food supplements and related products: coherent and comprehensive risk assessment and consumer information approaches. [Accessed November 14, 2005, 2005.]. Available at: http://www.efsa.eu.int/science/sc_commitee/sc_documents/616_en.html.
- Blumenthal M, editor. Herbal Medicine: Expanded Commision E Monographs. Newton, MA: Integrative Medicine Communications; 2003.
- Lloyd P, Lupton D, Wiesner D, Hasleton S. Choosing alternative therapy: an exploratory study of sociodemographic characteristics and motives of patients resident in Sydney. Aust J Public Health. 1993;17:135–144. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical